...
首页> 外文期刊>Carcinogenesis >Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidativen DNA damage and inhibition of estrogen-induced breast cancer
【24h】

Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidativen DNA damage and inhibition of estrogen-induced breast cancer

机译:抗氧化剂在雌性ACI大鼠中诱导NAD(P)H-醌氧化还原酶1与氧化性DNA损伤减少和雌激素诱导的乳腺癌抑制有关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Exact mechanisms underlying the initiation and progression of estrogen-related cancers are not clear. Literature, evidence and our studies strongly support the role of estrogen metabolism-mediated oxidative stress in estrogen-induced breast carcinogenesis. We have recently demonstrated that antioxidants vitamin C and butylated hydroxyanisole (BHA) or estrogen metabolism inhibitor α-naphthoflavone (ANF) inhibit 17β-estradiol (E2)-induced mammary tumorigenesis in female ACI rats. The objective of the current study was to identify the mechanism of antioxidant-mediated protection against E2-induced DNA damage and mammary tumorigenesis. Female ACI rats were treated with E2 in the presence or absence of vitamin C or BHA or ANF for up to 240 days. Nuclear factor erythroid 2-related factor 2 (NRF2) and NAD(P)H-quinone oxidoreductase 1 (NQO1) were suppressed in E2-exposed mammary tissue and in mammary tumors after treatment of rats with E2 for 240 days. This suppression was overcome by co-treatment of rats with E2 and vitamin C or BHA. Time course studies indicate that NQO1 levels tend to increase after 4 months of E2 treatment but decrease on chronic exposure to E2 for 8 months. Vitamin C and BHA significantly increased NQO1 levels after 120 days. 8-Hydroxydeoxyguanosine (8-OHdG) levels were higher in E2-exposed mammary tissue and in mammary tumors compared with age-matched controls. Vitamin C or BHA treatment significantly decreased E2-mediated increase in 8-OHdG levels in the mammary tissue. In vitro studies using silencer RNA confirmed the role of NQO1 in prevention of oxidative DNA damage. Our studies further demonstrate that NQO1 upregulation by antioxidants is mediated through NRF2.
机译:雌激素相关癌症的发生和发展的确切机制尚不清楚。文献,证据和我们的研究强烈支持雌激素代谢介导的氧化应激在雌激素诱导的乳腺癌致癌作用中的作用。我们最近证实抗氧化剂维生素C和丁基羟基茴香醚(BHA)或雌激素代谢抑制剂α-萘黄酮(ANF)抑制雌性ACI大鼠中17β-雌二醇(E2)诱导的乳腺肿瘤发生。当前研究的目的是确定抗氧化剂介导的针对E2诱导的DNA损伤和乳腺肿瘤发生的保护机制。在存在或不存在维生素C或BHA或ANF的情况下,对雌性ACI大鼠进行E2处理长达240天。用E2处理240天后,暴露于E2的乳腺组织和乳腺肿瘤中的核因子类红细胞2相关因子2(NRF2)和NAD(P)H-醌氧化还原酶1(NQO1)被抑制。通过用E2和维生素C或BHA共同治疗大鼠,可以克服这种抑制作用。时程研究表明,NQO1水平在E2治疗4个月后趋于增加,但在长期暴露于E2 8个月后趋于下降。 120天后,维生素C和BHA显着增加NQO1水平。与年龄相匹配的对照组相比,暴露于E2的乳腺组织和乳腺肿瘤中的8-羟基脱氧鸟苷(8-OHdG)水平更高。维生素C或BHA治疗可显着降低乳腺组织中E2介导的8-OHdG水平升高。使用沉默子RNA的体外研究证实了NQO1在预防DNA氧化损伤中的作用。我们的研究进一步证明,抗氧化剂对NQO1的上调是通过NRF2介导的。

著录项

  • 来源
    《Carcinogenesis》 |2012年第1期|p.156-163|共8页
  • 作者

    Hari K. Bhat;

  • 作者单位

    Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Room 5251, Kansas City, MO 64108, USA. Tel: +1 816 235 5903;

    Fax: +1 816 235 1776;

    Email:;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号